“HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIRECT IN VIVO DOSIMETRY IS AN IMPORTANT FACTOR IN INCREASING THE EFFECTIVENESS OF TREATMENT AND REDUCING THE INCIDENCE OF COMPLICATIONS”, Вопр. онкол., vol. 65, no. 4, pp. 596–602, Apr. 2019, doi: 10.37469/0507-3758-2019-65-4-596-602.